ISPOR - HTA155 Health Technology Assessment (HTA) of Respiratory Biologics: Highlighting the Differences in Value Assessment of Asthma Interventions Globally

Full Text

HTA155 Health Technology Assessment (HTA) of Respiratory Biologics: Highlighting the Differences in Value Assessment of Asthma Interventions Globally

Abstract

Authors

W Ahmed K Heffernan P Lembo J Carlson L Dimodica

Back to Volume 27, Supplemental Issue 12S

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now